爱康临床研究
ICLR
170.18
-4.95
-2.83%
爱康临床研究
US · ICLR
#1235 按市值排名
上市于 1970
170.18
-4.95
-2.83%
实时 - 追踪5344个代码 - 心跳于544秒前
· 2026-10-16 19:30
最新新闻
-
评级变动
Truist Financial Upgrades Icon PLC(ICLR.US) to Buy Rating, Announces Target Price $207\u5e02\u573a\u8d44\u8baf · 2026/6/30
-
评级变动
Truist Financial Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $207\u5e02\u573a\u8d44\u8baf · 2026/6/30
-
评级变动
J.P. Morgan Maintains Icon PLC(ICLR.US) With Hold Rating, Raises Target Price to $165\u5e02\u573a\u8d44\u8baf · 2026/8/5
-
评级变动
A Quick Look at Today's Ratings for Icon PLC(ICLR.US), With a Forecast Between $187 to $197\u5e02\u573a\u8d44\u8baf · 2026/6/26
-
评级变动
Truist Financial Maintains Icon PLC(ICLR.US) With Hold Rating\u5e02\u573a\u8d44\u8baf · 2026/6/24
-
BofA Securities Upgrades Icon PLC(ICLR.US) to Hold Rating\u5e02\u573a\u8d44\u8baf · 2026/10/9
-
RBC Capital Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $185\u5e02\u573a\u8d44\u8baf · 2026/10/7
-
UBS Initiates Icon PLC(ICLR.US) With Hold Rating, Announces Target Price $195\u5e02\u573a\u8d44\u8baf · 2026/9/30
-
评级变动
A Quick Look at Today's Ratings for Icon PLC(ICLR.US), With a Forecast Between $160 to $220\u5e02\u573a\u8d44\u8baf · 2026/7/31
-
UBS Maintains Icon PLC(ICLR.US) With Hold Rating, Maintains Target Price $195\u5e02\u573a\u8d44\u8baf · 2026/10/3
-
评级变动
Truist Financial Maintains Icon PLC(ICLR.US) With Buy Rating\u5e02\u573a\u8d44\u8baf · 2026/9/17
-
评级变动
BofA Securities Maintains Icon PLC(ICLR.US) With Sell Rating, Maintains Target Price $125\u5e02\u573a\u8d44\u8baf · 2026/6/24
-
评级变动
Mizuho Securities Maintains Icon PLC(ICLR.US) With Buy Rating, Raises Target Price to $190\u5e02\u573a\u8d44\u8baf · 2026/6/27
-
评级变动
William Blair Initiates Icon PLC(ICLR.US) With Buy Rating\u5e02\u573a\u8d44\u8baf · 2026/7/30
-
评级变动
Citi Maintains Icon PLC(ICLR.US) With Hold Rating, Raises Target Price to $175\u5e02\u573a\u8d44\u8baf · 2026/9/18
-
评级变动
Baird Maintains Icon PLC(ICLR.US) With Buy Rating, Raises Target Price to $194\u5e02\u573a\u8d44\u8baf · 2026/7/31
-
评级变动
A Quick Look at Today's Ratings for Icon PLC(ICLR.US), With a Forecast Between $160 to $197\u5e02\u573a\u8d44\u8baf · 2026/6/25
-
Barclays Maintains Icon PLC(ICLR.US) With Hold Rating, Maintains Target Price $175\u5e02\u573a\u8d44\u8baf · 2026/10/7
-
评级变动
TD Cowen Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $197\u5e02\u573a\u8d44\u8baf · 2026/8/3
-
评级变动
Barclays Maintains Icon PLC(ICLR.US) With Hold Rating, Raises Target Price to $160\u5e02\u573a\u8d44\u8baf · 2026/6/24
-
评级变动
RBC Capital Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $185\u5e02\u573a\u8d44\u8baf · 2026/7/31
-
评级变动
William Blair Maintains Icon PLC(ICLR.US) With Buy Rating\u5e02\u573a\u8d44\u8baf · 2026/6/2
-
Earnings Call Summary | Icon PLC(ICLR.US) Q1 2026 Earnings Conference\u5e02\u573a\u8d44\u8baf · 2026/8/31
新闻标题为自动聚合内容,未经我们团队独立核实或编辑。
报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
爱康临床研究 讨论区 0 条评论